Hemogenyx Pharmaceuticals PLC Announces HEMO-CAR-T Analytical Release Tests Completed

LONDON, UK / ACCESSWIRE / March 23, 2023 / Hemogenyx Pharmaceuticals plc ("Hemogenyx Pharmaceuticals" or the "Company") (LSE:HEMO), the biopharmaceutical group developing new therapies and treatments for deadly blood diseases, is pleased to announce …